SI

Sharmila Ingle

Active Director Director DIN 08883987
DIN 08883987 First appointment Sep 2020 Primary industry Life Sciences
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Sharmila Ingle

Data last updated:

Sharmila Ingle is a Director at Next Era Biochem Pharma Private Limited (since 2020). The company operates in Life Sciences.

DIN 08883987
Primary Designation Director
Industry Life Sciences
First Appointment 23 Sep 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Sep 20202020Active

Board colleagues of Sharmila Ingle

Directorship timeline

Open interactive timeline →
Next Era Biochem Pharma Private Limited
Premium access

Shareholding and investment profile for Sharmila Ingle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharmila Ingle

Sharmila Ingle currently holds 1 directorship: Next Era Biochem Pharma Private Limited (Director, since 23 Sep 2020).

Sharmila Ingle was first appointed on 23 Sep 2020 as Director at Next Era Biochem Pharma Private Limited.

The current boards of Sharmila Ingle's companies include Arpita Vyas (Next Era Biochem Pharma Private Limited), Naman Mandloi (Next Era Biochem Pharma Private Limited), Ritam Mandloi (Next Era Biochem Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available